FDA Lifts Boston Scientific Warning Letter Restrictions On PMA Approvals
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific anticipates FDA approval of its Express SD renal stent, among other products, now that the agency has lifted the restrictions on Class III device approvals imposed by a 2006 company-wide warning letter